Port Capital LLC Takes $9.57 Million Position in Revvity Inc. $RVTY

Port Capital LLC purchased a new stake in shares of Revvity Inc. (NYSE:RVTY) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 85,992 shares of the company’s stock, valued at approximately $9,567,000. Port Capital LLC owned about 0.08% of Revvity as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC acquired a new position in shares of Revvity during the second quarter valued at $32,000. Ascentis Independent Advisors acquired a new stake in Revvity in the first quarter worth about $29,000. MUFG Securities EMEA plc acquired a new stake in Revvity in the second quarter worth about $34,000. Global Retirement Partners LLC bought a new stake in Revvity during the 2nd quarter worth about $51,000. Finally, Headlands Technologies LLC acquired a new position in Revvity during the 2nd quarter valued at about $49,000. 86.65% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Robert W. Baird set a $117.00 price target on shares of Revvity in a research report on Wednesday, May 6th. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Weiss Ratings upgraded shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. Finally, Stifel Nicolaus decreased their price objective on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $108.36.

Revvity Stock Up 1.2%

RVTY stock opened at $126.31 on Thursday. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $14.09 billion, a PE ratio of 60.15, a PEG ratio of 2.27 and a beta of 1.07. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $126.90. The business’s 50 day simple moving average is $112.94 and its 200 day simple moving average is $100.82.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The business had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. During the same quarter last year, the firm posted $1.18 EPS. The company’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, research analysts anticipate that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s dividend payout ratio is presently 13.33%.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.